Statement from FDA Commissioner Robert Califf, M.D. announcing new draft guidances on medical produc
We recognize that there is a high level of interest regarding FDA’s views on communications about medical products. We are committed to an ongoing dialogue with industry and other stakeholders, and, when needed, providing guidance to clarify the agency’s
2017-01-19 ·
fda.gov